home / stock / sybx / sybx news


SYBX News and Press, Synlogic Inc.

Stock Information

Company Name: Synlogic Inc.
Stock Symbol: SYBX
Market: NASDAQ
Website: synlogictx.com

Menu

SYBX SYBX Quote SYBX Short SYBX News SYBX Articles SYBX Message Board
Get SYBX Alerts

News, Short Squeeze, Breakout and More Instantly...

SYBX - SYBX Stock Earnings: Synlogic Misses EPS, Misses Revenue for Q1 2024

2024-05-14 13:54:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Synlogic (NASDAQ: SYBX ) just reported results for the first quarter of 2024. Synlogic reported earnings per share of -$2.60. This was below the analyst estimate for EPS o...

SYBX - Synlogic GAAP EPS of -$2.60 misses by $1.80

2024-05-14 07:20:24 ET More on Synlogic Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial information for Synlogic Read the full article on Seeking Alpha For further details see: Synlogic GAAP EPS of -...

SYBX - Synlogic Reports First Quarter 2024 Financial Results

CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the first quarter 2024 and provided a corporate update. In March 2024, t...

SYBX - Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M

2024-03-19 07:13:14 ET More on Synlogic Synlogic shares crater amid company shut down, failed drug study Synlogic to discontinue lead drug program, cease operations Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic ...

SYBX - Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full year ending December 31, 2023. The Company...

SYBX - Synlogic Adopts Limited Duration Stockholders Rights Plan

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today announced that its Board of Directors (the “Board”) has approved the adoption of a limited dur...

SYBX - US Companies Moving the Markets, Morning edition
Mon, Feb 12, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 97.9% to $0.23 on volume of 419,200,402 shares Sunworks Inc. (SUNW) rose 87.9% to $0.1022 on volume of 385,386,904 shares Green Giant Inc. (GGE) rose 15.4% to $0.0427 on volume of 208,454,257 s...

SYBX - US Companies Moving the Markets, Evening edition
Fri, Feb 09, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 121.6% to $0.2575 on volume of 398,287,485 shares Sunworks Inc. (SUNW) rose 116.6% to $0.11785 on volume of 366,627,028 shares Green Giant Inc. (GGE) rose 15.1% to $0.0426 on volume of 195,208,...

SYBX - SUNW and MSS among mid-day movers

2024-02-09 12:50:35 ET More on Mid-day movers & stocks. BioXcel Therapeutics, Inc. (BTAI) Q3 2023 Earnings Call Transcript Sunworks files for Chapter 7 bankruptcy BioXcel slumps after Q3 pipeline update Seeking Alpha’s Quant Rating on BioXcel Thera...

SYBX - Synlogic shares crater amid company shut down, failed drug study

2024-02-09 11:58:34 ET More on Synlogic Synlogic to discontinue lead drug program, cease operations Synlogic provides corporate update, outlook for 2024 Seeking Alpha’s Quant Rating on Synlogic Historical earnings data for Synlogic Financial in...

Next 10